CA2172377A1 - Nouveaux lactames du type 4-piperidinyle substitues utilises en tant qu'antagonistes du recepteur de neurokinine 2 dans le traitement de l'asthme - Google Patents

Nouveaux lactames du type 4-piperidinyle substitues utilises en tant qu'antagonistes du recepteur de neurokinine 2 dans le traitement de l'asthme

Info

Publication number
CA2172377A1
CA2172377A1 CA002172377A CA2172377A CA2172377A1 CA 2172377 A1 CA2172377 A1 CA 2172377A1 CA 002172377 A CA002172377 A CA 002172377A CA 2172377 A CA2172377 A CA 2172377A CA 2172377 A1 CA2172377 A1 CA 2172377A1
Authority
CA
Canada
Prior art keywords
alkyl
formula
bear
hydroxy
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002172377A
Other languages
English (en)
Inventor
Scott Carson Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca UK Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2172377A1 publication Critical patent/CA2172377A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

Des composés de la formule (I) dans laquelle J, B, L, X, m et M ont les notations données dans la description de l'invention, leurs oxydes azotés ainsi que leurs sels pharmacologiquement acceptables sont des antagonistes non peptidiques de la neurokinine A, et sont utiles dans le traitement de l'asthme, etc. L'invention se rapporte également aux compositions pharmaceutiques, aux procédés de préparation des composés de formule (I) ainsi qu'à leurs intermédiaires.
CA002172377A 1993-11-03 1994-10-31 Nouveaux lactames du type 4-piperidinyle substitues utilises en tant qu'antagonistes du recepteur de neurokinine 2 dans le traitement de l'asthme Abandoned CA2172377A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9322643.9 1993-11-03
GB939322643A GB9322643D0 (en) 1993-11-03 1993-11-03 Lactam derivatives

Publications (1)

Publication Number Publication Date
CA2172377A1 true CA2172377A1 (fr) 1995-05-11

Family

ID=10744560

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002172377A Abandoned CA2172377A1 (fr) 1993-11-03 1994-10-31 Nouveaux lactames du type 4-piperidinyle substitues utilises en tant qu'antagonistes du recepteur de neurokinine 2 dans le traitement de l'asthme

Country Status (12)

Country Link
US (2) US5534525A (fr)
EP (1) EP0726893B1 (fr)
JP (1) JP3534765B2 (fr)
AT (1) ATE187963T1 (fr)
AU (1) AU8000594A (fr)
CA (1) CA2172377A1 (fr)
DE (1) DE69422303T2 (fr)
DK (1) DK0726893T3 (fr)
ES (1) ES2139760T3 (fr)
GB (1) GB9322643D0 (fr)
GR (1) GR3032253T3 (fr)
WO (1) WO1995012577A1 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325074D0 (en) * 1993-12-07 1994-02-02 Zeneca Ltd Bicyclic heterocycles
US5589489A (en) * 1993-12-15 1996-12-31 Zeneca Limited Cyclic amide derivatives for treating asthma
GB9408872D0 (en) * 1994-05-03 1994-06-22 Zeneca Ltd Heterocyclic compounds
TW432061B (en) * 1994-08-09 2001-05-01 Pfizer Res & Dev Lactams
US5998444A (en) * 1995-10-24 1999-12-07 Zeneca Ltd. Piperidinyl compounds as NK1 or NK2 antagonists
DE69534213T2 (de) * 1994-10-25 2006-01-12 Astrazeneca Ab Therapeutisch wirksame Heterocyclen
US6008223A (en) * 1994-10-27 1999-12-28 Zeneca Limited Therapeutic compounds
GB9421709D0 (en) * 1994-10-27 1994-12-14 Zeneca Ltd Therapeutic compounds
GB9508786D0 (en) 1995-04-29 1995-06-21 Zeneca Ltd Substituted heterocycles
US5696267A (en) * 1995-05-02 1997-12-09 Schering Corporation Substituted oximes, hydrazones and olefins as neurokinin antagonists
US5688960A (en) * 1995-05-02 1997-11-18 Schering Corporation Substituted oximes, hydrazones and olefins useful as neurokinin antagonists
FR2738245B1 (fr) * 1995-08-28 1997-11-21 Sanofi Sa Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant
GB9523526D0 (en) * 1995-11-17 1996-01-17 Zeneca Ltd Therapeutic compounds
GB9601697D0 (en) * 1996-01-27 1996-03-27 Pfizer Ltd Therapeutic agents
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
US5998439A (en) * 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
US5789422A (en) * 1996-10-28 1998-08-04 Schering Corporation Substituted arylalkylamines as neurokinin antagonists
TR200001437T2 (tr) * 1997-11-21 2000-10-23 Schering Corporation Nörokinin muhasımlar olarak eşdeğer edilen oksimler.
GB9924141D0 (en) * 1998-10-30 1999-12-15 Zeneca Ltd Treatment of gastric asthma
US6063926A (en) * 1998-11-18 2000-05-16 Schering Corporation Substituted oximes as neurokinin antagonists
JP4370059B2 (ja) * 1998-12-23 2009-11-25 シェーリング コーポレイション ニューロキニンアンタゴニストとしての置換オキシムおよびヒドラゾン
GB0015246D0 (en) * 2000-06-22 2000-08-16 Astrazeneca Ab Method for the treatment of urinary incontinence
SE0103795D0 (sv) * 2001-11-02 2001-11-02 Astrazeneca Ab Compounds and method for the treatment of överactive bladder
TW200508221A (en) 2003-06-13 2005-03-01 Astrazeneca Ab New azetidine compounds
GB0326407D0 (en) * 2003-11-12 2003-12-17 Glaxo Group Ltd Chemical compounds
GB0412865D0 (en) * 2004-06-09 2004-07-14 Glaxo Group Ltd Chemical compounds
AR057828A1 (es) 2005-09-29 2007-12-19 Astrazeneca Ab Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
US20070219214A1 (en) * 2006-02-01 2007-09-20 Solvay Pharmaceuticals Gmbh Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation
US8106208B2 (en) 2006-05-18 2012-01-31 Albireo Ab Benzamide compounds that act as NK receptor antagonists

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE903957A1 (en) * 1989-11-06 1991-05-08 Sanofi Sa Aromatic amine compounds, their method of preparation and¹pharmaceutical compositions in which they are present
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
FR2676053B1 (fr) * 1991-05-03 1993-08-27 Sanofi Elf Nouveaux composes dialkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2688219B1 (fr) * 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
GB9321557D0 (en) * 1992-11-03 1993-12-08 Zeneca Ltd Carboxamide derivatives
GB9310066D0 (en) * 1993-05-17 1993-06-30 Zeneca Ltd Alkyl substituted heterocycles
GB9310713D0 (en) * 1993-05-24 1993-07-07 Zeneca Ltd Aryl substituted heterocycles
GB9317104D0 (en) * 1993-08-17 1993-09-29 Zeneca Ltd Therapeutic heterocycles
GB9325074D0 (en) * 1993-12-07 1994-02-02 Zeneca Ltd Bicyclic heterocycles
US5589489A (en) * 1993-12-15 1996-12-31 Zeneca Limited Cyclic amide derivatives for treating asthma
US5434158A (en) * 1994-04-26 1995-07-18 Merck & Co., Inc. Spiro-substituted azacycles as neurokinin-3 antagonists
GB9408872D0 (en) * 1994-05-03 1994-06-22 Zeneca Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
JPH09505036A (ja) 1997-05-20
EP0726893B1 (fr) 1999-12-22
GR3032253T3 (en) 2000-04-27
EP0726893A1 (fr) 1996-08-21
US5677317A (en) 1997-10-14
DK0726893T3 (da) 2000-05-29
JP3534765B2 (ja) 2004-06-07
ES2139760T3 (es) 2000-02-16
AU8000594A (en) 1995-05-23
US5534525A (en) 1996-07-09
GB9322643D0 (en) 1993-12-22
DE69422303D1 (de) 2000-01-27
ATE187963T1 (de) 2000-01-15
DE69422303T2 (de) 2000-05-18
WO1995012577A1 (fr) 1995-05-11

Similar Documents

Publication Publication Date Title
EP0726893B1 (fr) Nouveaux lactames du type 4-piperidinyle substitues utilises en tant qu'antagonistes du recepteur de neurokinine 2 dans le traitement de l'asthme
US5559131A (en) Carboxamide derivatives for treating asthma
EP0714392B1 (fr) Heterocycles aptes a etre utilises comme antagonistes de la neurokinine
US5731309A (en) Substituted heteroalkyleneamine neurokinin antagonists
CA2124048A1 (fr) Derives de substitution aryliques d'heterocycles
US5602138A (en) NKA affecting piperidyl heterobicyclic compounds
CA2344807A1 (fr) Naphtalene-carboxamides utilises en tant qu'antagonistes des recepteurs des tachykinines
US6355695B1 (en) Substituted heterocycles

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued